Mergers & Acquisitions ·
FTC issues Second Request for Lantheus-Curium merger review, extending HSR waiting period
LNTHLantheus Holdings, Inc.
The Federal Trade Commission issued a Second Request for additional information and documentary materials regarding the proposed merger between Lantheus Holdings, Inc. and Curium US Holdings LLC. This regulatory action extends the Hart-Scott-Rodino Act waiting period until 30 days after both parties substantially comply with the request. The company expects to respond promptly and continue cooperating with the FTC. Completion of the transaction remains subject to the expiration or termination of this waiting period, with the parties still targeting consummation in the first half of 2027. Lantheus Holdings develops and commercializes diagnostic imaging agents for nuclear medicine.